Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SABS SAB Biotherapeutics > Detailed Quotes

SABS SAB Biotherapeutics

Watchlist
0.670
-0.009-1.33%
Trading Session  02/01 14:43 ET
High
0.700
Open
0.690
Turnover
11.54K
Low
0.670
Pre Close
0.679
Volume
16.94K
Market Cap
33.77M
P/E(TTM)
Loss
52wk High
5.890
Shares
50.39M
P/E(Static)
Loss
52wk Low
0.501
Float Cap
19.04M
Bid/Ask %
-33.33%
Historical High
12.900
Shs Float
28.41M
Volume Ratio
0.58
Historical Low
0.501
Dividend TTM
--
Div Yield TTM
--
P/B
0.94
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.06%
Amplitude
4.40%
Avg Price
0.681
Lot Size
1
Float Cap
19.04M
Bid/Ask %
-33.33%
Historical High
12.900
Shs Float
28.41M
Volume Ratio
0.58
Historical Low
0.501
Dividend TTM
--
P/B
0.94
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
4.40%
Avg Price
0.681
Lot Size
1
Price Forecast

News

Comment

Company Overview More
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton and is headquartered in Sioux Falls, SD.
CEO: Dr. Eddie J. Sullivan, PhD
Market: NASDAQ
Listing Date: 02/09/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist